COVID-19 LAB TESTS RECEIVING FDA EMERGENCY USE AUTHORIZATION ((s) = Serology Test (a) = Antigen Test (t) = Total Antibody Test (m) = Multi-analyte Test) Date Manufacturer(s) Test … [Read more...]
FDA Watch
Agency Greenlights First Over-the-Counter, At-Home COVID-19 Testing Kit
January 10, 2021
Nearly 250 COVID-19 diagnostic tests have gotten Emergency Use Authorization (EUA) from the FDA since the pandemic started. Almost all of them have been prescription products. In addition, 25 test … [Read more...]
M&A Review
2020 M&A Year in Review: Deal Making Was Low in Volume but High in Impact
January 10, 2021
Not surprisingly, the COVID-19 pandemic exerted a pronounced chilling effect on M&A activity in the diagnostic space as both buyers and sellers adopted a wait-and-see attitude. But the decline in … [Read more...]
M&A Report
CompuGroup Medical Makes Major LIS Play by Acquiring Schuyler House
January 10, 2021
It seems fitting that the pandemic year of 2020 should end not with a bang but a whimper. December was the slowest month in M&A deal making of not only this year but many years in recent memory … [Read more...]
Inside the Lab Industry
Abbott and Quidel Stake Out Early Claims for Leadership of SARS-CoV-2 Rapid Antigen Testing Market
January 6, 2021
What COVID-19 antigen assays lack in accuracy with regard to RT-PCR testing is offset by their speed, low cost and scalability. In the long term, these advantages make point-of-care COVID-19 antigen … [Read more...]
Laboratory Industry Report Newsletter Archive
January 1, 2021
By clicking on any of the links below you agree that you are the only person who is accessing your single user LIR subscription license and that you are not sharing your username and password with … [Read more...]
Current Issue of LIR
January 1, 2021
Before You Download Please read the following user agreement and confirm your acceptance of the terms before you download LIR content: I agree that I am the the only person who is accessing my … [Read more...]
M&A Report
Look for Health Care Mergers and Acquisitions to Resurge in 2021
December 2, 2020
Last year at this time, the expectation was that 2020 would be an unusually active year for health care mergers and acquisitions. But the pandemic forced deal makers to shelve their plans and await … [Read more...]
